Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Osteoporosis (PMO)”

9 trials

Showing 9 of 9 results

Large-scale testing (Phase 3)Study completedNCT05215977
What this trial is testing

Efficacy and Safety of MW031 in PMO Subjects

Who this might be right for
Osteoporosis, Postmenopausal
Mabwell (Shanghai) Bioscience Co., Ltd. 448
Not applicableStudy completedNCT07294105
What this trial is testing

Relationship Between Periodontal Disease and Postmenopausal Osteoporosis

Who this might be right for
Periodontal DiseasePostmenopausal Osteoporosis (PMO)
Recep Tayyip Erdogan University 80
Testing effectiveness (Phase 2)Study completedNCT01992159
What this trial is testing

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis (PMO)
Amgen 252
Post-approval studies (Phase 4)Study completedNCT00549965
What this trial is testing

Satisfaction and Compliance of Risedronate in PMO

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 202
Not applicableStudy completedNCT02520362
What this trial is testing

Denosumab Safety Assessment in Multiple Observational Databases

Who this might be right for
Osteoporosis
Amgen 517,991
Large-scale testing (Phase 3)Study completedNCT00247273
What this trial is testing

Monthly Risedronate for Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Warner Chilcott 1,294
Large-scale testing (Phase 3)Study completedNCT00577421
What this trial is testing

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Who this might be right for
Postmenopausal Osteoporosis
Warner Chilcott 32
Not applicableStudy completedNCT02422069
What this trial is testing

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 624
Large-scale testing (Phase 3)Study completedNCT00909961
What this trial is testing

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Who this might be right for
Postmenopausal Osteoporosis
Novartis Pharmaceuticals 118

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation